A carregar...
Octreotide-Targeted Lcn2 siRNA PEGylated Liposomes as a Treatment for Metastatic Breast Cancer
Lcn2 overexpression in metastatic breast cancer (MBC) can lead to cancer progression by inducing the epithelial-to-mesenchymal transition and enhancing tumor angiogenesis. In this study, we engineered a PEGylated liposomal system encapsulating lipocalin 2 (Lcn2) small interfering RNA (Lcn2 siRNA) fo...
Na minha lista:
| Publicado no: | Bioengineering (Basel) |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8067132/ https://ncbi.nlm.nih.gov/pubmed/33916786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/bioengineering8040044 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|